Methods for the diagnosis and treatment of cancer based on AVL9

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110229505A1
SERIAL NO

13051701

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for the diagnosis and treatment of cancer in mammals, in particular gastric cancer, based on the new target AVL9. The present invention thus relates to diagnostic methods and related components to be used in such methods. Furthermore, the present invention relates to the treatment of cancer in mammals, in particular gastric cancer, based on AVL9 as a target. Specifically, the present invention relates to the immunotherapy of cancer using AVL9 tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides, and respective pharmaceutical compositions, in particular vaccine compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMATICS BIOTECHNOLOGIES GMBHPAUL-EHRLICH-STRASSE 15 TUEBINGEN 72076

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FRITSCHE, Jens Tuebingen, DE 754 5610
LEWANDROWSKI, Peter Tuebingen-Hirschau, DE 37 1171
SCHOOR, Oliver Tuebingen, DE 721 5294
SINGH, Harpreet Tuebingen, DE 775 8815
WALTER, Steffen Reutlingen, DE 175 3860
WEINSCHENK, Toni Aichwald, DE 760 8126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation